News for hackers. Stuff that matters.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by matthewtoast on Friday May 22, 2020 @12:47PM (#23274080)
Yes, and the practitioners boosting the drug combo have also said that in order to be effective, it should be administered early, similar to Tamiflu.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by marvin on Friday May 22, 2020 @01:06PM (#23274366)
Was this done in the study linked?

All doctors I’ve seen promote hydroxychloroquine have been adamant that it must be administered early in the disease’s progression in order to have any effect.

But most of the studies being performed that I’ve heard of, have explicitly been on late-stage patients. This includes the central EU study.

It would be tragic if the drug works when administered early, but all the studies have happened at a late stage, incorrectly disqualifying a treatment that can save many lives.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by rsynnott on Friday May 22, 2020 @01:55PM (#23274974)
As mentioned in the paper they only include people where the drug was given within 48 hours after diagnosis.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by giardini on Friday May 22, 2020 @03:57PM (#23276232)
48 hours is two days! "48 hours after diagnosis" is NOT early treatment. See my earlier post!
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by Khelavaster on Friday May 22, 2020 @03:17PM (#23275825)
So, the time between when symptoms first started and up to 48 hours after patients' test results came back positive.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by dmix on Friday May 22, 2020 @12:52PM (#23274153)
I'm curious why there hasn't been a proper prophylactic study of HCQ. Every test I see are hospitalized and late stage. The vast majority of people are told to quarantine at home after testing positive.

I'm sure a test group could be made among them to test for severity of symptoms + testing to see the number who are later hospitalized.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by rsynnott on Friday May 22, 2020 @01:05PM (#23274346)
Giving a dangerous drug to healthy people (presumably thousands of them, to be statistically useful), on no real evidence of efficacy, would be ethically dubious, to say the least.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by Khelavaster on Friday May 22, 2020 @03:15PM (#23275806)
There's plenty of evidence hydroxychloroquine works for SARS.

How would you justify giving hydroxychloroquine to hundreds of thousands of healthy people a year for malaria prophylaxis?

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by marvin on Friday May 22, 2020 @01:08PM (#23274388)
GP wasn’t suggesting prophylactic use on healthy people. The suggestion was to do this on diagnosed patients, maybe in risk groups, that haven’t progressed to a serious condition yet. But would be at great risk (>10%) to do so soon.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by meheleventyone on Friday May 22, 2020 @01:22PM (#23274583)
But this study is on outcomes where the treatment was administered within 48 hours of diagnosis.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by giardini on Friday May 22, 2020 @03:55PM (#23276196)
48 hours after _diagnosis_ is pretty damned late. To rephrase that, it's "Two days after diagnosis"!

I'd expect the lungs to be fully invaded and serious damage done by the virus by that time. This is not an early, or even seriously prompt, treatment. Certainly if the patients were in a hospital setting this would be unacceptably slow treatment.

This appears to be yet another of several "studies" where HCQ was given late to patients that were already near death. Of course it had little effect.

The recommendation was always HCQ + AZITHROMYCIN + ZINC SULFATE given EARLY. Few, if any, studies have followed that recommendation.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by marvin on Friday May 22, 2020 @04:11PM (#23276402)
This debate would be EASILY settled by doing real science like you suggest. Instead, we get these proud Trump debunkings that don’t answer the important question. Ok, HCQ doesn’t help critical patients. But we’ve already suspected that for two months.

I don’t get it. Just do a simple, proper frickin’ study where the cocktail you mention is used immediately after diagnosis, and compare outcomes with different treatments.

This seems so obvious that I wish someone could point out to me what obvious detail I’m not understanding. It’s as if proving Trump wrong is more important than answering the real and important yes/no question.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by marvin on Friday May 22, 2020 @04:04PM (#23276311)
Thanks. That settles my question. It was administered much later than suggested by most doctors that have tentatively used it based on experiences with malaria and SARS.

So it’s sadly not very useful for drawing conclusions about that :(

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by matthewtoast on Friday May 22, 2020 @01:12PM (#23274448)
As we would with any drug, we'd start with a small group and scale it to more as it was determined to be safe.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by rurban on Tuesday May 26, 2020 @01:46AM (#23307813)
Excuse me. It is know to be safe for 70 years. It used widescale in the whole world. It is cheap and easily manifacturable (only India is doing it right now). It is known to be working as COVID-19 prophylaxe (not as treatment). There is no vaccination in sight.

https://www.icmr.gov.in/pdf/covid/techdoc/V5_Revised_advisor...

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by brutt on Friday May 22, 2020 @01:11PM (#23274429)
HCQ is given to millions in USA alone, since 1955.

https://en.wikipedia.org/wiki/Hydroxychloroquine

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by rurban on Tuesday May 26, 2020 @01:41AM (#23307783)
It is not a dangerous drug at all. Dangerous is CQ phosphat/Resochin, which was used only for a short time in history, until it was replaced by HCQ. In the 40ies already, at the German Africa campaign.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by michaelmrose on Friday May 22, 2020 @12:49PM (#23274124)
So if we kill another thousand people administering it differently how likely are we to discover it now works instead of substantially increasing mortality?
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by matthewtoast on Friday May 22, 2020 @12:56PM (#23274203)
I don't know. We should follow whatever procedures we follow when testing any potential new treatment.
Re:Hydroxychloroquine Covid-19: a multinational registry ana... by DanBC on Friday May 22, 2020 @01:14PM (#23274472)
> Tamiflu.

Another drug that doesn't work nearly as well as some people think. https://www.bmj.com/tamiflu

> The reviewers concluded that there was no convincing trial evidence that Tamiflu affected influenza complications (in treatment) or influenza infections (in prophylaxis), and raised new questions about the drug’s harms profile.

Re:Hydroxychloroquine Covid-19: a multinational registry ana... by Khelavaster on Friday May 22, 2020 @03:22PM (#23275876)
> Hayashi pointed out that the key piece of evidence underpinning the previous Cochrane review’s conclusion--that Tamiflu reduced the risk of secondary complications such as pneumonia--was based on a manufacturer-authored, pooled analysis of 10 manufacturer-funded trials

Everything needed for FDA approval.

> no convincing trial evidence

It just sounds like Tamiflu efficacy studies to date haven't been thorough enough to be convincing.